SCHEMBL362208

SCHEMBL362208

CCCCCC([O])CCCC

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.48
LCK P06239 1/20 0.46
PPARD Q03181 1/20 0.46
ZDHHC20 Q5W0Z9 1/20 0.46
ZDHHC2 Q9UIJ5 1/20 0.46
OPRM1 P35372 1/20 0.46
CA2 P00918 1/20 0.44
FDPS P14324 5/20 0.44
GPR84 Q9NQS5 3/20 0.42
FFAR1 O14842 1/20 0.42
CA1 P00915 1/20 0.42
LMNA P02545 1/20 0.42
ZDHHC7 Q9NXF8 1/20 0.41
TSHR P16473 1/20 0.41
THRB P10828 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9249296 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL7813115 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL9253135 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL6435941 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL8974845 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL17386385 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL3633977 0.97 DNM1 (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL3090884 0.97 LCK (0.48) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL10335495 0.94 LCK (0.52) DNM1LCKPPARDZDHHC20ZDHHC2
SCHEMBL8862993 0.94 LCK (0.52) DNM1LCKPPARDZDHHC20ZDHHC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117603175-A Chalcone derivative with benzopyran structure, and preparation method and application thereof 南开大学 2024-02-27 CN claimed
US-20230093056-A1 COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION UNIV CASE WESTERN RESERVE (US) 2023-03-23 US claimed
CN-114721223-A Photosensitive resin, photosensitive resin composition, cured product, pattern forming method, and integrated circuit device 华为技术有限公司 2022-07-08 CN claimed
US-10727414-B2 Functional hole transport materials for optoelectronic and/or electrochemical devices ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) 2020-07-28 US claimed
CN-111349447-A Liquid crystal compound containing difluoromethoxy bridge bond, preparation method and application 河北迈尔斯通电子材料有限公司 2020-06-30 CN claimed
CN-110526832-A A method of preparing polysubstituted alicyclic compound UNIV ZHEJIANG NORMAL 2019-12-03 CN claimed
US-20190334092-A1 DISPIRO-OXEPINE/THIAPINE DERIVATIVES FOR OPTOELECTRONIC SEMICONDUCTORS QATAR FOUNDATION FOR EDUCATION, SCIENCE AND COMMUNITY DEVELOPMENT (QA) 2019-10-31 US claimed
CN-105264440-B Anti-corrosion agent composition 三菱瓦斯化学株式会社 2019-09-24 CN claimed
CN-106459603-B Fluorescent reactive dye, preparation method and application thereof 德司达染料分销有限公司 2019-08-23 CN claimed
US-10351577-B2 Ether analogues of galiellalactone GLACTONE PHARMA DEVELOPMENT AB (SE) 2019-07-16 US claimed
US-4665216-A Process for producing n-acyl-acyloxy aromatic amines CELANESE CORPORATION (US) 1987-05-12 US claimed
EP-0200211-A1 Diagnostic radiopharmaceutical compounds THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1986-11-05 EP claimed
CN-86101066-A Process for producing novel trifluoromethyl ketone substituted peptide derivatives 1986-11-05 CN claimed
CN-85101170-A The method of olefinic polymerization and vanadium catalyst 1986-10-08 CN claimed
CN-85109716-A Preparation octahydro indoles is (2,3-α) quinolizine-1-base-alkane hydroxy acid acid amides and acid salt thereof and the method that contains their pharmaceutical composition also 1986-10-08 CN claimed
EP-0194849-A2 Improved process for producing N-acyl-acyloxy aromatic amines CELANESE CORPORATION (US) 1986-09-17 EP claimed
EP-0189057-A2 5-Aryl-dihydropyridines, process for their preparation as well as use in medicaments BAYER AG (DE) 1986-07-30 EP claimed
US-4568763-A Process for producing N-acyl-acyloxy aromatic amines CELANESE CORPORATION (US) 1986-02-04 US claimed
EP-0168908-A1 Process for producing N-acyl-acyloxy aromatic amines CELANESE CORPORATION (US) 1986-01-22 EP claimed
EP-0010366-B1 SOLID ORGANOMETALLIC INORGANIC POLYMERS AND THEIR APPLICATION OCCIDENTAL RESEARCH CORPORATION (US) 1983-02-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230093056-A1 COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION AKR1A1, AKR1B1, AKR1C2 DNM1 1530/4885LCK 3379/4885PPARD 1729/4885
US-10351577-B2 Ether analogues of galiellalactone GALE, GALK1, PGLS DNM1 3687/4885LCK 1704/4885PPARD 750/4885
US-10727414-B2 Functional hole transport materials for optoelectronic and/or electrochemical devices SLCO2A1, SLCO4C1, SLCO1A2 DNM1 1879/4885LCK 2524/4885PPARD 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.